Journal rankings · indicator year 2005
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2005
Cellular and Molecular Neuroscience journal rankings 2005
32 ranked journals · Subfield in Neuroscience
Cellular and Molecular Neuroscience has 32 ranked journals in 2005. The median journal has an OJR of 0.89, below the world average of 1.00, up 0.03 on 2004; Q1 starts at OJR 1.32. The top three are Brain Research Reviews, Neuropsychopharmacology, and Critical Reviews in Neurobiology.
Ranks and citation indicators: 2005. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2002–2004, the window the 2005 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Neuroscience (8)
32 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2004. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2002–2004, the window the 2005 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2002–2004 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2005. | Compare |
|---|---|---|---|---|---|---|---|
1Brain Research ReviewsElsevier BV · Netherlands | 2.84Q1 | 6.60 0.21 down from 2004 | 219 | 6% | — | ||
2NeuropsychopharmacologySpringer Nature · United States | 1.97Q1 | 5.58 0.91 up from 2004 | 816 | 18% | $5,290 | ||
3Critical Reviews in NeurobiologyBegell House · United States | 1.77Q1 | 3.66 0.09 up from 2004 | 35 | 17% | — | ||
4PsychopharmacologySpringer Science+Business Media · Germany | 1.54Q1 | 4.36 0.51 up from 2004 | 1,124 | 9% | $4,390 | ||
5Journal of NeurobiologyWiley · United States | 1.51Q1 | 3.94 0.55 down from 2004 | 436 | 9% | — | ||
6NeuropharmacologyElsevier BV · Netherlands | 1.39Q1 | 4.09 0.26 up from 2004 | 780 | 5% | $4,300 | ||
7NeuroRxSpringer Nature · United States | 1.33Q1 | 2.51no 2004 value | 63 | 100% | — | — | |
8Journal of Neuroscience ResearchWiley · United States | 1.32Q1 | 3.60 0.49 down from 2004 | 1,137 | 9% | $4,840 | ||
9The Journal of Comparative NeurologyWiley · United States | 1.29Q2 | 4.32 0.63 up from 2004 | 1,323 | 17% | $5,450 | ||
10CNS Drug ReviewsWiley · United States | 1.22Q2 | 3.33 0.14 up from 2004 | 67 | 86% | — | ||
11SynapseWiley · United States | 1.07Q2 | 3.40 0.35 up from 2004 | 381 | 8% | $3,570 | ||
12Journal of Comparative Physiology ASpringer Science+Business Media · Germany | 1.00Q2 | 2.23 0.08 down from 2004 | 322 | 9% | $3,990 | ||
13Journal of NeurocytologySpringer Nature · Netherlands | 1.00Q2 | 2.12 0.06 down from 2004 | 200 | 15% | — | ||
14Pharmacology Biochemistry and BehaviorElsevier BV · United States | 0.98Q2 | 2.24 0.58 down from 2004 | 943 | 8% | $3,650 | ||
15AlcoholElsevier BV · United Kingdom | 0.96Q2 | 2.02no change | 223 | 6% | $3,720 | ||
16Molecular Brain ResearchElsevier BV · Netherlands | 0.93Q2 | 2.27 0.02 down from 2004 | 977 | 4% | — | ||
17NeuropeptidesElsevier BV · United Kingdom | 0.86Q3 | 2.00 0.71 down from 2004 | 160 | 5% | $3,530 | ||
18Journal of Chemical NeuroanatomyElsevier BV · Netherlands | 0.85Q3 | 2.23 0.27 up from 2004 | 202 | 3% | $3,230 | ||
19Behavioural PharmacologyLippincott Williams & Wilkins · United Kingdom | 0.84Q3 | 2.16 0.10 down from 2004 | 213 | 1% | — | ||
20Addiction BiologyOAWiley · United Kingdom | 0.84Q3 | 1.97 0.42 up from 2004 | 151 | 2% | $3,150 | ||
21Developmental Brain ResearchElsevier BV · Netherlands | 0.81Q3 | 1.82 0.61 down from 2004 | 618 | 5% | — | ||
22Regulatory PeptidesElsevier BV · Netherlands | 0.81Q3 | 2.13 0.23 down from 2004 | 675 | 6% | — | ||
23The CerebellumSpringer Science+Business Media · United Kingdom | 0.73Q3 | 1.64 0.30 up from 2004 | 105 | 8% | $4,790 | ||
24Pharmacology & ToxicologyWiley · Denmark | 0.73Q3 | 1.67 0.10 up from 2004 | 219 | — | — | ||
25Journal of Neurosurgery PediatricsUnited States | 0.73Q4 | 1.29no 2004 value | 92 | — | — | — | |
26Brain Research ProtocolsElsevier BV · Netherlands | 0.67Q4 | 1.70 0.62 up from 2004 | 156 | 9% | — | ||
27min - Minimally Invasive NeurosurgeryThieme Medical Publishers (Germany) · Germany | 0.55Q4 | 1.08 0.18 up from 2004 | 220 | 0% | — | ||
28Child s Nervous SystemSpringer Science+Business Media · Germany | 0.54Q4 | 1.13 0.23 down from 2004 | 443 | 3% | $4,790 | ||
29Neuron Glia BiologyCambridge University Press · United Kingdom | 0.51Q4 | 1.14no 2004 value | 42 | 20% | — | — | |
30Journal of NeurogeneticsTaylor & Francis · Switzerland | 0.43Q4 | 0.97 0.17 up from 2004 | 51 | 0% | — | ||
31Cerebrospinal Fluid ResearchOABritish Motor Corporation · United Kingdom | 0.09Q4 | 0.19no 2004 value | 70 | 100% | $1,680 | — | |
32Neuroscience Research CommunicationsWiley · United Kingdom | 0.09Q4 | 0.20 0.14 down from 2004 | 98 | — | — |
Subfields of Neuroscience, with Cellular and Molecular Neuroscience highlighted.
- Cognitive Neuroscience177
- Cellular and Molecular Neuroscience32
- Neurology9
- Sensory Systems4
- Behavioral Neuroscience3
- Biological Psychiatry2
- Endocrine and Autonomic Systems2
- Developmental Neuroscience1
Journals
Citations made in 2005. Corpus-wide, 70.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
3 additional Cellular and Molecular Neuroscience journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2002–2004, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2005. Publication window: 2002–2004. How these summaries are calculated
- Ranked journals
- 32
- Window papers (baseline)
- 38,123 -0.2% from indicator year 2002
- Median OJR
- 0.894 +8.1% from indicator year 2002
- Rising journals (2025)
- 1
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2002–2004 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 27 | 27 | 26 | 27 | 27 | 32 | 32 | 32 | 31 | 27 | 30 | 32 | 33 | 32 | 30 | 30 | 32 | 32 | 29 | 32 | 33 | 33 | 33 | 32 | 31 | 30 | |
| Window papers (baseline) | 37,773 | 38,664 | 38,213 | 37,940 | 37,414 | 38,123 | 38,289 | 38,810 | 38,951 | 41,086 | 41,577 | 41,975 | 41,244 | 41,433 | 42,264 | 42,615 | 42,554 | 41,749 | 40,554 | 39,909 | 39,604 | 39,824 | 40,023 | 39,750 | 39,038 | 38,750 | |
| Median OJR | 0.73 | 0.74 | 0.83 | 0.790 | 0.86 | 0.894 | 0.91 | 0.885 | 0.94 | 1.16 | 1.18 | 1.12 | 1.07 | 1.147 | 1.14 | 1.153 | 1.13 | 1.149 | 1.146 | 1.04 | 1.004 | 0.997 | 0.93 | 0.88 | 0.90 | 0.791 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.